BCL2L1 and neoplasm: DNA copy number alteration is a driver of tumorigenesis, and many oncogenes have increased copy numbers in tumor cells, including c-Myc, FGFR, BCL2L1, DLC1, PRKC1, Sox2 and so on [26].